the adaptogens market is projected to grow from usd 8.96 billion in 2025 to usd 12.81 billion by 2036, at a cagr of 3.3%. the leading nature segment share should be verified before publication, while ashwagandha will lead the adaptogen type segment with a 26.0% share.